In modern biotech, the bottleneck is no longer the ability to generate data. Sequencers, mass spectrometers and high-throughput assays flood laboratories with terabytes daily. The challenge is turning that raw biological noise into actionable insight.
READ MOREWelcome to the age of synthetic agency.
READ MOREThe development of novel small molecule therapeutics has long been constrained by fundamental limitations in molecular exploration. Traditional approaches screen thousands of compounds to identify a single viable candidate and often fail to account for the intricacies of drug-target interactions, leading to high attrition rates in clinical trials.
READ MOREWhat if you could predict the next breakthrough molecule before your competitors even begin screening?
READ MOREThe most profound revolutions don't announce themselves with fanfare. They creep up quietly, rewiring civilisation before we've even noticed. Now, another quiet revolution is unfolding: the rise of AI Factories.
READ MOREToday, NVIDIA isn’t simply developing AI – it’s industrialising it. AI Factories aren’t some distant concepts; they’re the next evolution of computing infrastructure, already transforming industries, accelerating discoveries and redefining what’s possible.
READ MOREWe are witnessing a fundamental shift in how computing infrastructure is designed and deployed. Find out how you can stay ahead of the curve with Boston and NVIDIA.
READ MORETo help our clients make informed decisions about new technologies, we have opened up our research & development facilities and actively encourage customers to try the latest platforms using their own tools and if necessary together with their existing hardware. Remote access is also available
The International Conference for High Performance Computing, Networking, Storage, and Analysis